| http://www.w3.org/ns/prov#value | - In addition, the implementation of certain TRIPS requirements does not yet appear to be complete, particularly in relation to the lack of legal protection of confidential information submitted by pharmaceutical companies to obtain marketing approval for drugs. (Source: EuroCham Indonesia, Position Paper 2011)
|
